InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (10 ops.)
Browse the full record of transactions filed by Lorrain Daniel S., Chief Scientific Officer. Officer active across 1 companies, notably Contineum Therapeutics, Inc.. In total, 12 filings have been recorded. Total volume traded: €410k. The latest transaction was disclosed on 1 May 2026 — Cession. Regulator: SEC (Form 4). The full history is free.
Declarations12 total
US$43,0913,870 shares@ US$11.134720.6% of flow
Class A Common Stock
SEC:0001628280-26-029435·
€43,0913,870 shares@ €11.13470.010% mcap10.3% of flow
Class A Common Stock
SEC:0001628280-26-029435:0·
US$48,5344,170 shares@ US$11.638823.2% of flow
Class A Common Stock
SEC:0001628280-26-023949·
€48,5344,170 shares@ €11.63880.011% mcap11.6% of flow
Class A Common Stock
SEC:0001628280-26-023949:0·
US$3,6824,300 shares@ US$0.85641.8% of flow
Class A Common Stock
SEC:0001437749-26-005889·
€3,6824,300 shares@ €0.85640.0009% mcap0.9% of flow
Class A Common Stock
SEC:0001437749-26-005889:0·
US$37,6893,000 shares@ US$12.563118.1% of flow
Class A Common Stock
SEC:0001437749-26-003212·
€37,6893,000 shares@ €12.56310.0088% mcap9.0% of flow
Class A Common Stock
SEC:0001437749-26-003212:0·
US$32,4473,670 shares@ US$8.841215.5% of flow
Class A Common Stock
SEC:0001437749-26-000616·
€32,4473,670 shares@ €8.84120.0076% mcap7.8% of flow
Class A Common Stock
SEC:0001437749-26-000616:0·
US$43,3534,170 shares@ US$10.396420.8% of flow
Class A Common Stock
SEC:0001437749-25-038936·
€43,3534,170 shares@ €10.39640.010% mcap10.4% of flow
Class A Common Stock
SEC:0001437749-25-038936:0·
12 of 12 declarations
About Lorrain Daniel S.
Lorrain Daniel S. serves as Chief Scientific Officer at Contineum Therapeutics, Inc. In this role, he oversees the company's research and development activities. His expertise in biological sciences enables him to lead innovation projects and ensure product quality. Daniel plays a key role in implementing research and development strategies.
